Pictet Asset Management
BPMC

Pictet Asset Management’s Blueprint Medicines BPMC Stock Holding History

Pictet Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-119,817
Closed -$15.4M – 2036
2025
Q2 		$15.4M Sell
119,817
-834,779
-87% -$86.7M 0.02% 574
2025
Q1 		$84.5M Sell
954,596
-229,086
-19% -$22.3M 0.09% 225
2024
Q4 		$103M Buy
1,183,682
+17,175
+1% +$1.57M 0.11% 195
2024
Q3 		$108M Buy
1,166,507
+39,205
+3% +$3.89M 0.12% 188
2024
Q2 		$122M Sell
1,127,302
-737,236
-40% -$73.8M 0.14% 170
2024
Q1 		$177M Buy
1,864,538
+110,991
+6% +$9.52M 0.19% 142
2023
Q4 		$162M Buy
1,753,547
+997,219
+132% +$64.6M 0.18% 144
2023
Q3 		$38M Buy
+756,328
New +$40.4M 0.05% 331

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management's BPMC Position: Q3 2025 in Review

Pictet Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 119,817 shares — an estimated $15.4M sold.

Pictet Asset Management first reported a position in BPMC in Q3 2023 and held it in 8 quarters. The position peaked at $177M in Q1 2024. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Pictet Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Pictet Asset Management sold 119,817 Blueprint Medicines shares in Q3 2025, an estimated $15.4M.
  • Pictet Asset Management first reported a position in Blueprint Medicines in Q3 2023 and held it in 8 quarters.
  • Pictet Asset Management's Blueprint Medicines position peaked at $177M in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Pictet Asset Management's 13F filing for Q3 2025, filed 18 Nov 2025.